Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

NCT04193553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Gastro Intestinal Stromal Tumour

Interventions

DRUG: Lenvatinib
DRUG: Placebo
OTHER: Best supportive care

Sponsor

Centre Leon Berard